Events /// Investor News /// Investment Case /// Resources
Bayer is committed to providing sustainable solutions that address humanity’s most fundamental needs for essential healthcare and nutritious food. The Bayer Investor Relations Team is dedicated to creating transparency, fostering dialogue, and delivering value to our stakeholders.
Upcoming Events and Highlights
Investor News
Share Price / Index
April 08, 2025
Not intended for U.S. and UK Media
Bayer files for approval of aflibercept 8 mg for treatment of retinal vein occlusion in EU
April 04, 2025
Bayer announces filing of petition to U.S. Supreme Court for review of Durnell Roundup™ case
March 26, 2025
Not intended for U.S. and UK Media
Bayer and Puhe BioPharma enter into global license agreement for clinical phase I PRMT5 inhibitor
Discover More
